- Home
- ELWS vs PHIO Comparison
ELWS vs PHIO Comparison
Compare ELWS & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELWS
- PHIO
- Stock Information
- Founded
- ELWS 2018
- PHIO 2011
- Country
- ELWS Japan
- PHIO United States
- Employees
- ELWS N/A
- PHIO N/A
- Industry
- ELWS
- PHIO Biotechnology: Pharmaceutical Preparations
- Sector
- ELWS
- PHIO Health Care
- Exchange
- ELWS Nasdaq
- PHIO Nasdaq
- Market Cap
- ELWS 12.9M
- PHIO 12.1M
- IPO Year
- ELWS 2023
- PHIO N/A
- Fundamental
- Price
- ELWS $4.23
- PHIO $2.14
- Analyst Decision
- ELWS
- PHIO Strong Buy
- Analyst Count
- ELWS 0
- PHIO 3
- Target Price
- ELWS N/A
- PHIO $10.67
- AVG Volume (30 Days)
- ELWS 1.7M
- PHIO 70.7K
- Earning Date
- ELWS 09-30-2025
- PHIO 11-13-2025
- Dividend Yield
- ELWS N/A
- PHIO N/A
- EPS Growth
- ELWS N/A
- PHIO N/A
- EPS
- ELWS N/A
- PHIO N/A
- Revenue
- ELWS $3,083,071.00
- PHIO N/A
- Revenue This Year
- ELWS N/A
- PHIO N/A
- Revenue Next Year
- ELWS N/A
- PHIO N/A
- P/E Ratio
- ELWS N/A
- PHIO N/A
- Revenue Growth
- ELWS 145.52
- PHIO N/A
- 52 Week Low
- ELWS $1.64
- PHIO $0.97
- 52 Week High
- ELWS $10.50
- PHIO $9.79
- Technical
- Relative Strength Index (RSI)
- ELWS 57.75
- PHIO 47.27
- Support Level
- ELWS $4.07
- PHIO $2.08
- Resistance Level
- ELWS $4.75
- PHIO $2.17
- Average True Range (ATR)
- ELWS 0.92
- PHIO 0.10
- MACD
- ELWS 0.03
- PHIO -0.01
- Stochastic Oscillator
- ELWS 24.01
- PHIO 25.64
About ELWS Earlyworks Co. Ltd.
Earlyworks Co Ltd is a blockchain-based technology company. It builds products, delivers services, and develops solutions based on a proprietary grid ledger system to leverage blockchain technology in various business settings, including advertisement tracking, online visitor management, and sales of non-fungible tokens. The company's customers represent a diverse range of industries, such as information technology, shipping, real estate, entertainment, cosmetics, and chemical products.
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.